It has been reported that the inhibition of the Wnt/β-catenin pathway is associated with the upregulation of the PI3K/AKT/mTORC1 pathway in CRC, and blocking the PI3K/AKT/mTORC1 pathway results in Wnt/β-catenin signaling hyperactivation as a compensatory mechanism [135]. This evidence concerns the gene AKT1 and colorectal carcinoma.